Dr. Reddy’s Renames Injectables Research Unit
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered integrated pharmaceutical company, has renamed Octoplus, its Leiden, Netherlands-based research center, and affiliated legal entities of OctoPlus to Dr. Reddy’s Research and Development B.V.,…

3M in Cancer Vaccine Delivery Pact
By

By
3M Drug Delivery Systems has entered a new phase in an ongoing collaboration with Panacea Pharmaceuticals, a Gaithersburg, Maryland-headquartered pharmaceutical company focused on therapies for cancer and neurodegenerative diseases, in…

BMS, Merck & Co. in $625-Million Settlement for Keytruda Patent Litigation
By

By
Bristol-Myers Squibb (BMS) and its partner, Ono Pharmaceutical Company, headquartered in Osaka, Japan, have signed a global patent license agreement with Merck & Co. to settle all patent-infringement litigation related…

Takeda Partners in Rare Pediatric Epilepsies
By

By
Takeda Pharmaceutical has formed a global collaboration with Ovid Therapeutics, a privately held New York-based biopharmaceutical company specializing in therapeutics for rare neurological diseases, for the clinical development and commercialization…

Takeda Makes Cash Tender Offer for Ariad
By

By
Takeda Pharmaceutical has begun a cash tender offer, through its wholly owned indirect subsidiary, Kiku Merger, for all outstanding shares of the common stock of Ariad Pharmaceuticals, Cambridge, Massachusetts-headquartered oncology-focused pharmaceutical company…

Perrigo Recalls Acne Medicine on Mold Issues
By

By
Perrigo has issued a voluntary Class II recall of 162,534 tubes of clindamycin phosphate and benzoyl peroxide gel, a prescription acne medication, due to mold contamination. Perrigo initiated the recall…

AbbVie, Bristol-Myers Squibb, and Roche Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from AbbVie, Bristol-Myers Squibb, Gilead, Roche, and Shire. Editor’s Note:…

AbbVie, Allergan, and Sanofi Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AbbVie, Allergan, Perrigo, Sanofi, and Teva. Editor’s Note: This article is updated on a continuous basis…

BI in Cloud Platform Deal for Healthcare Management
By

By
Boehringer Ingelheim, on behalf of its diabetes alliance with Eli Lilly and Company, has entered into an agreement with Inovalon, a Bowie, Maryland-based technology company providing cloud-based platforms for the…

Merck KGaA Partners in Immuno-Oncology
By

By
Merck KGaA has signed a collaboration and license agreement with Domain Therapeutics, a biopharmaceutical company headquartered in Strasbourg, France, for the development of adenosine receptor antagonist drugs specifically designed for…